VIC Investor Network Introduces a Secondary Market for Members

Provides VIN Members Early Liquidity Options FAYETTEVILLE, AR. DECEMBER 14, 2020- The VIC Investor Network (“VIN”) makes investments into companies based on technologies that can have substantial impact on human health...

SFC Fluidics, Inc. Receives FDA Breakthrough Device Designation

FDA’s BDD program targets novel devices with the potential to provide patients with a more effective treatment for life-threatening or irreversibly debilitating diseases. SFC’s insulin pod promises to substantially...

VIC Portfolio Company, BlueInGreen, Acquired by Chart Industries

Arkansas-based cleantech company tapped to lead Chart’s global water and wastewater treatment markets Water cleantech company BlueInGreen, LLC—provider of the most efficient method of dissolving oxygen, carbon dioxide...

Inside The VIC Fellows Program

VIC Technology Venture Development’s (www.victech.com) investment model sources promising life science innovation directly from universities across the nation, allocating funding to form startup companies and advance...

VIC Fellows Spotlight: Travis Nemkov, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Tesseract Structural Innovations and Cymat Technologies Announce Co-Operation Agreement

Combines Tesseract’s engineered product innovations and Cymat’s stabilized aluminum foam in automotive, aerospace, transportation, nuclear transport, military and defense applications.

VIC Foundry: An Incubator for High Impact Life Science Technologies

What is VIC Foundry? VIC Foundry is one element of the VIC innovation ecosystem. It develops technologies sourced from top research institutions in the U.S. with the potential to have substantial impact and commercial...

Sustainability as Strategy: A Discussion with BlueInGreen

A Discussion with BlueInGreen Chief Marketing + Sustainability Officer Tyler Elm For those unfamiliar with BlueInGreen, tell us a little about the Company. BlueInGreen (BIG) is a remarkable, water clean-tech company....

VIC Fellow Spotlight: Dr. Greg Tucker

The VIC Fellows Program was created in late 2019 as a mechanism for individuals with specific expertise to learn about and be involved in identifying and evaluating promising life science innovations from universities,...

Partner Spotlight: OmniValley

VIC is pleased to work with OmniValley in supporting their mission to better connect fund and startup company investors to one another. OmniValley is an exclusive, online investor network built to offer connections for...

The Anatomy of a Friends and Family Round in a COVID-19 World

When I wrote about fundraising early this year, I knew that I would be raising a round shortly, but had no idea I would be doing it in a changed COVID-19 world. I have experienced two unexpected recessions as an...

Opportunity Assessment: How To Vet So Much Tech

How do you successfully evaluate hundreds of complicated technologies each year, with a team spread across the country and resources that span the globe? This was the challenge that VIC needed to solve back in early...

Solenic Medical Receives FDA Breakthrough Device Designation

TEXAS – July 29, 2020 – Solenic Medical, a developer of a device that uses alternating magnetic fields to treat a prosthetic joint infections (PJI) announced today that it has received Breakthrough Device designation...

Partner Spotlight: SeedSprint

SeedSprint is the innovation ecosystem that connects emerging technologies with industry partners. The platform is free for emerging technology companies and research institutions and available to industry at a flat...

VIC 2020 Mid-Year Update

So far, in 2020, VIC’s portfolio of companies reached numerous milestones and potential business partners are increasingly finding ways to re-engage in spite of the ongoing pandemic. The VIC Foundry has expanded...

Vixiar: Solving a Big Problem With a Small Device

Last month at Vixiar Medical, we reached a major milestone on the road to commercial launch of our Indicor™ device with the submission of our 510(k) to the FDA. We hope to have clearance to market our product in the...

Portfolio Diversification in Times of Market Volatility

Update It is now March 2021, and nine months after writing this piece below, saying that things have evolved would be an understatement. Focusing on the positive progress made to date, we have three approved vaccines in...

The Emerging Remote Workplace: Digital Best Practices for Investor Groups

As the recent pandemic has made all too clear, organizations need to proactively prepare for the realities of a dispersed workforce, which is especially true for investor groups such as venture capital and private...

Neurexis Therapeutics Awarded Colorado Advanced Industries Accelerator Grant

AURORA, CO - Neurexis Therapeutics, Inc. announced today that it has been approved for funding as part of the Colorado Office of Economic Development and International Trade’s (OEDIT) Advanced Industries Accelerator...

Zebra Analytix Awarded NIH Funding to Improve Workplace Safety

FAYETTEVILLE, AR - Zebra Analytix—a VIC Technology Venture Development portfolio company—announced today that it has received a Small Business Innovation Research (SBIR) grant from the National Institute of...

VIC Fellow Spotlight: Dr. Natalie Gassman

The VIC Fellows Program was created in late 2019 as a mechanism for individuals with specific expertise to learn about and be involved in identifying and evaluating promising life science innovations from universities,...

Why VIC Sometimes Steps Outside Its Life Science Focus

VIC Technology Venture Development primarily is focused on building companies around high-impact life science technologies, including medical devices, therapeutics, diagnostics, and advanced instrumentation. More than...

CardioWise Makes FDA Submission With Request for Expedited Approval for COVID-19

This month, CardioWise filed a 510(k) Application for its machine learning-based heart health analysis software known as SQuEEZTM. The software, combined with cardiac computerized tomography (CT) imaging, has the...

Enjoy The Ride: Inside an Automotive Startup

Startups are known to be roller coaster rides, but what do you get when you launch an automotive industry startup? A really wild ride! The past year or so has indeed been a wild ride since I took over as CEO of...

BlueInGreen Uses Wastewater Treatment Technology to Fight COVID-19

With workers, communities and corporations around the globe joining the battle against COVID-19, one company is attacking the virus from an unexpected angle: water.

VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact

Our current daily activities bear little resemblance to the routines as of as recently as a month ago. COVID-19 has had an obvious and significant impact on the American people. For those suffering from chronic...

From The Corner Office: SFC Fluidics Nears FDA Submission

“Did you eat too much candy as a child?” “You don’t look diabetic…you are not at all overweight.” “You just have to watch your sugar intake, right?” These are typical, insensitive comments that people with diabetes...

VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics

Neurexis Therapeutics, Inc. to develop a new medication for the prevention of brain damage following ischemic events such as stroke

VIC Launches New Fellows Program

The VIC Fellows Program was created as a mechanism through which individuals with specific expertise can learn about and be involved in the process of identifying and evaluating promising life science innovation from...

VIC Technology Venture Development Forms New Portfolio Company: Filtravate

Company co-founded with Reza Foudazi, PhD, developer of a platform membrane technology with broad applications in bioprocessing and industrial filtration.

Failing to fundraise can be the downfall of startups

Startups are pulling outsized financing rounds and debt acquisitions at an unprecedented rate despite the high 80 percent failure rate of startups overall. Among the three primary reasons why startups tend to fail,...

An Interview with Darlene Boudreaux: CEO, Investor, and Entrepreneur

Can you tell us a little bit about your background and experience? I was a founder and CEO of a pharmaceutical manufacturing company, and then took over and grew a nonprofit medical technology incubator, helping others...

VIC 2019 Annual Report

In the past year, VIC’s portfolio of companies reached numerous milestones, the VIC Investor Network (VIN) experienced its first exit, and we added important new elements to the VIC ecosystem. While progress in 2019 was...

Behind the Curtain with Biolocity | Guiding Medical Innovations to Market

Please start off by describing your current role with Biolocity and the organization’s unique model. I am the Managing Director for Biolocity, which is a philanthropic, multi-institutional program that accelerates the...

White Paper: New Paradigms of Life Science Investing

For decades, only venture capital (VC) firms, and very rarely, angels were able to invest in start-up companies developing life science—therapeutics, medical devices, diagnostics, and related—innovation. Anyone doing so...

A Letter from our CEO 2020

Welcome to the 20s! To my ears, 2020 sounds very futuristic – but we are living it. The pace of technological change continues to accelerate and have profound impact on all of us. VIC’s motto is Technology Solutions for...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.